25 results
Keyword Bridion Remove keyword
-
List item
Human medicine European public assessment report (EPAR): Bridion
sugammadex, Neuromuscular Blockade
Date of authorisation: 25/07/2008, Revision: 17, Authorised, Last updated: 08/10/2020Bridion Neuromuscular Blockade … Bridion … Bridion, INN-sugammadex 30 … -
List item
Press release: Meeting highlights from the Committee for Medicinal Products for Human Use,27-30 May 2008
CHMP, Last updated: 02/06/2008the following medicines: Bridion (sugammadex), from N.V. Organon … following medicines: • Bridion (sugammadex), from N.V. Organon … -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 4-7 February 2013
European Medicines Agency, London, UK, from 04/02/2013 to 07/02/2013, Last updated: 02/06/2012 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 1-3 October 2012
European Medicines Agency, London, UK, from 01/10/2012 to 03/10/2012, Last updated: 02/06/2012 -
List item
News: European Medicines Agency increases transparency of ongoing applications for human medicines
PRAC, Last updated: 07/11/2012 -
List item
PRAC: Committee agendas, minutes and meeting highlights report archive 2012-2013
Last updated: 01/01/2015 -
List item
PRAC: meeting archive 2012-2013
Last updated: 13/05/2016 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 8-11 April 2013
European Medicines Agency, London, UK, from 08/04/2013 to 11/04/2013, Last updated: 02/06/2012 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 29-31 October 2012
European Medicines Agency, London, UK, from 29/10/2012 to 31/10/2012, Last updated: 03/12/2012 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 6-9 January 2014
European Medicines Agency, London, UK, from 06/01/2014 to 09/01/2014, Last updated: 13/08/2013 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 13-16 May 2013
European Medicines Agency, London, UK, from 13/05/2013 to 16/05/2013, Last updated: 02/07/2012 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 2-5 September 2013
European Medicines Agency, London, UK, from 02/09/2013 to 05/09/2013, Last updated: 02/07/2012 -
List item
Download medicine data
Last updated: 29/04/2020 -
List item
PRAC recommendations on safety signals: monthly overviews: Archive
Last updated: 30/05/2017 -
List item
News: 2012 annual report on EudraVigilance published
Last updated: 26/07/2013 -
List item
PRAC: Agendas, minutes and highlights (updated)
Last updated: 16/02/2021 -
List item
CHMP: Agendas, minutes and highlights
Last updated: 29/01/2021 -
List item
Public data from Article 57 database (updated)
Last updated: 16/02/2021 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 30 August - 2 September 2016
European Medicines Agency, London, UK, from 30/08/2016 to 02/09/2016, Last updated: 13/03/2014 -
List item
Management Board meeting: 4-5 March 2009
European Medicines Agency, London, UK, from 04/03/2009 to 05/03/2009, Last updated: 01/09/2011 -
List item
Committee for Medicinal Products for Human Use (CHMP): 22-25 February 2021
European Medicines Agency, Amsterdam, the Netherlands, from 22/02/2021 to 25/02/2021, Last updated: 04/11/2019 -
List item
Annual reports and work programmes
Last updated: 15/06/2020 -
List item
PRAC: meeting archive 2014-2015
Last updated: 13/05/2016 -
List item
Press release: EMEA reports strong performance in regulatory and public-health activities in 2007; the outlook for 2008 is even higher application numbers and a focus on advanced-therapy medicines
Last updated: 10/03/2008 -
List item
CHMP: meeting archive 2001-2009
Last updated: 18/11/2013